NDC 60505-6214
ICATIBANT
Icatibant Acetate
ICATIBANT is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Apotex Corp.. The primary component is Icatibant Acetate.
| Product ID | 60505-6214_626483ed-d5c0-49d9-b8f8-3fd1920118ca |
| NDC | 60505-6214 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ICATIBANT |
| Generic Name | Icatibant Acetate |
| Dosage Form | Injection, Solution |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2020-12-18 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA212081 |
| Labeler Name | Apotex Corp. |
| Substance Name | ICATIBANT ACETATE |
| Active Ingredient Strength | 30 mg/3mL |
| Pharm Classes | Bradykinin B2 Receptor Antagonist [EPC],Bradykinin B2 Receptor Antagonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |